SenzaGen AB (SENZA.ST)

SEK 7.0

(0.0%)

Long Term Debt Summary of SenzaGen AB

SenzaGen AB's latest annual long term debt in 2023 was 1.67 Million SEK , up 38.61% from previous year.
SenzaGen AB's latest quarterly long term debt in 2024 Q2 was 4.25 Million SEK , up 69.75% from previous quarter.
SenzaGen AB reported annual long term debt of 1.2 Million SEK in 2022, up 69.05% from previous year.
SenzaGen AB reported annual long term debt of 714 Thousand SEK in 2021, down 0.0% from previous year.
SenzaGen AB reported quarterly long term debt of 2.5 Million SEK for 2024 Q1, up 49.79% from previous quarter.
SenzaGen AB reported quarterly long term debt of 1.67 Million SEK for 2023 Q3, up 53.91% from previous quarter.

Annual Long Term Debt Chart of SenzaGen AB (2023 - 2014)

Historical Annual Long Term Debt of SenzaGen AB (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	1.67 Million SEK	38.61%
2022	1.2 Million SEK	69.05%
2021	714 Thousand SEK	0.0%
2020	- SEK	0.0%
2019	- SEK	0.0%
2018	- SEK	0.0%
2017	- SEK	0.0%
2016	- SEK	-100.0%
2015	1.5 Million SEK	0.0%
2014	- SEK	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	4.25 Million SEK	69.75%
2024 Q1	2.5 Million SEK	49.79%
2023 Q3	1.67 Million SEK	53.91%
2023 Q1	1.08 Million SEK	-9.94%
2023 FY	1.67 Million SEK	38.61%
2023 Q4	1.67 Million SEK	0.0%
2023 Q2	1.08 Million SEK	0.0%
2022 Q3	1.2 Million SEK	0.0%
2022 Q4	1.2 Million SEK	0.0%
2022 FY	1.2 Million SEK	69.05%
2022 Q2	- SEK	0.0%
2022 Q1	- SEK	-100.0%
2021 Q1	- SEK	0.0%
2021 FY	714 Thousand SEK	0.0%
2021 Q4	714 Thousand SEK	0.0%
2021 Q3	714 Thousand SEK	0.0%
2021 Q2	- SEK	0.0%
2020 Q3	- SEK	0.0%
2020 Q1	- SEK	0.0%
2020 Q2	- SEK	0.0%
2020 FY	- SEK	0.0%
2020 Q4	- SEK	0.0%
2019 Q4	- SEK	0.0%
2019 FY	- SEK	0.0%
2019 Q2	- SEK	0.0%
2019 Q1	- SEK	0.0%
2019 Q3	- SEK	0.0%
2018 Q2	- SEK	0.0%
2018 Q3	- SEK	0.0%
2018 Q4	- SEK	0.0%
2018 Q1	- SEK	0.0%
2018 FY	- SEK	0.0%
2017 Q3	- SEK	0.0%
2017 Q4	- SEK	0.0%
2017 Q1	- SEK	0.0%
2017 Q2	- SEK	0.0%
2017 FY	- SEK	0.0%
2016 FY	- SEK	-100.0%
2016 Q3	- SEK	0.0%
2016 Q4	- SEK	0.0%
2016 Q1	- SEK	0.0%
2015 FY	1.5 Million SEK	0.0%
2014 FY	- SEK	0.0%

Peer Long Term Debt Comparison of SenzaGen AB

Name	Long Term Debt	Long Term Debt Difference
AroCell AB (publ)	- SEK	-Infinity%
Devyser Diagnostics AB (publ)	600 Thousand SEK	-178.833%
Immunovia AB (publ)	1.78 Million SEK	6.379%
Prostatype Genomics AB (publ)	67 Thousand SEK	-2397.015%
Spermosens AB	230 Thousand SEK	-627.391%